Santa Cruz Biotechnology offers a broad range of CD15s monoclonal antibodies for research applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD15s, also known as sialylated Lewis X, is a carbohydrate antigen expressed on the surface of certain immune cells and is involved in cell adhesion and signaling processes. CD15s plays a crucial role in the immune response and is often associated with inflammation and cancer metastasis. Understanding CD15s expression patterns helps researchers investigate cellular interactions during immune responses. CD15s research has revealed significant insights into leukocyte trafficking and tumor cell behavior. Studying CD15s expression contributes to the development of new therapeutic approaches for inflammatory diseases and cancer treatment. Ongoing research continues to uncover new functions of CD15s in health and disease. CD15s investigation is vital for advancing our understanding of immune system regulation and cancer progression. Santa Cruz Biotechnology monoclonal antibodies for CD15s support researchers worldwide in advancing scientific discoveries and developing innovative therapeutic strategies.